MagicTOUCH AVF

Sirolimus coated balloon

A functioning dialysis access (AVF/AVG) is critical for the delivery of life-saving hemodialysis therapy to patients with kidney failure.

MagicTouch AVF is intended for stenotic lesions in dysfunctional arteriovenous fistulas and vascular prostheses.

Advantages

• Sirolimus acts cytostatic - not cytotoxic
• Optimum Sirolimus binding to the balloon surface thanks to Nanolute technology
• 100% balloon coating
• Slow tissue absorption
• Effective Sirolimus transfer into deeper vessel layers
• High Sirolimus bioavailability

NANOLUTE TECHNOLOGY is designed to improve the lipophilicity and bioavailability of Sirolimus

Phospholipid is a drug carrier with two lipophilic tails and one hydrophilic head.
Sirolimus is encapsulated in phospholipid with proprietary Nanolute technology.